{{knowledge objective
|Identifiant=OIC-233-12-B
|Item_parent=Valvulopathies
|Item_parent_short=Valvulopathies
|Rank=B
|Title=Knowing the medical treatment of AI
|Description=Beta-blocker in Marfan's disease
|Topic=Management
|Contributors=Myriam Akodad,Florence Leclercq
|Order=12}}

*Medical treatment is indicated in cases of AI with no indication for surgery.
*Treatment is based on :
Hygienic and dietary rules: low salt diet'' **''Pharmacological treatment'': low salt diet''
**Pharmacological treatment'' :
***IEC/ARA 2, +/- diuretics
***In case of Marfan (or dilatation of the ascending aorta): beta-blockers or ARB 2 (Losartan) to slow down the dilatation of the aorta.
**Prevention of infective endocarditis: oral hygiene/6 months, follow-up.
**'''Family screening''' if Marfan's disease or bicuspidia<ins> (first-degree relatives)</ins> **'''Monitoring''' of aortic dilatation in aorta
**'''Monitoring''': clinical, ECG and ETT:
***6 months-1 year in moderate to severe asymptomatic IA.
***Every year if Aorta >40mm
***Every 2 years if minimal IA